(STOCKHOLM) Symcel — a company providing continuous metabolic measurements of living organisms — today announced a new rights issue worth 86 MSEK, financed by a consortium of private health and technology investors including Lareim AB and Flerie...
– The funding will also accelerate the commercialization of Symcel’s R&D product offering (STOCKHOLM) Symcel — a company providing real-time metabolic measurements of living organisms with their analytical instrument the calScreener™ ̶ today...
– New antibiotic potentiating activity has been discovered for treatment of Cystic Fibrosis associate infections. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for bacteria and cell culture with their product the...
– A new screening method will help to discover drugs that force the body to burn fat reserves. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™ ̶ was recently involved in a...
– Metabolic readouts highlighted which treatment parameters were most effective. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™ ̶ was recently involved in a publication...
(STOCKHOLM) Symcel — a company providing real-time metabolic measurements for cell culture with their product the calScreener™ ̶ was recently featured in a peer-reviewed publication showing that metastatic potential of certain tumours is related to...
(STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product calScreener™ ̶ was recently featured in a peer-reviewed publication showing how metabolic data shed new light on the evolution of...
– New data suggest old antibiotics used in new combinations can be effective against drug resistant infections. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product calScreener™ ̶ was recently...
We find ourselves in the middle of a global pandemic that is causing a great deal of uncertainty from international governments to individual families. With that in mind, I want Symcel’s position to be clear throughout and we will be posting regular...
COVID-19 is forcing everyone to reconsider how they work. At Symcel, while we place a lot of value on personal interactions, we also have strong digital workflows that allow us to do our jobs remotely. These workflows have prepared us for the...